Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
about
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancerIn vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenograftsBioluminescent monitoring of NIS-mediated (131)I ablative effects in MCF-7 xenografts.Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoterEpidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene deliverySodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene deliveryImage-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Stimulation of cultured h9 human embryonic stem cells with thyroid stimulating hormone does not lead to formation of thyroid-like cells.A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer.Progress in gene therapy for prostate cancerThe glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant gliomaStromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.The Na+/I- symporter (NIS): mechanism and medical impact.The biology of the sodium iodide symporter and its potential for targeted gene delivery.The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation.Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy.In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.[Study on the iodine 125 uptake of H460 lung cancer cell line by co-transfection with the human sodium/iodide symporter and the human thyroperoxidase].(124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice.
P2860
Q33603806-CA1A414B-AE42-45DC-8561-6240F8033597Q33670033-1BC6E49D-C658-498A-89AB-84BC123988CCQ33704207-42FE8170-4723-485B-B217-F25D17718FE8Q34018755-C57662B4-9730-424F-9DB1-5C7ECFC8B171Q34159598-A8083F34-63B1-4AFC-84C4-0650978765BFQ34209727-AF3CF060-0F28-496E-A0AA-2C13E3F81470Q34303955-A88F5600-B939-40AA-9114-9CA4E94809C3Q34512455-963E6F84-BB8E-469A-A860-CE2AB6F3C311Q34757186-5F0C7E2E-2B0D-44F4-89B7-84A9F472CF4BQ35125290-49E0C57A-E623-4F73-A88C-0DF1C4CDF0CDQ35238289-DB3BCBAD-E012-481A-8BAF-5A2E6C0233F9Q35575677-75DF0AEB-2E02-4BD1-9C47-24BA25D4C865Q35612571-85B5CE33-A860-4D9C-B94F-AEA61D9CA897Q35949806-72E6F218-4116-4274-BF01-28A6AB1DAE30Q36403691-2A2B662C-B91A-411B-98A4-D21D629005ACQ36406911-399A27F7-E4A0-43B2-B3AF-DAD30C5C61A6Q36611803-8D17E606-26D9-46C0-98B2-AD7779C66627Q36720696-8E1DE280-AB68-498D-AE3E-DD3FD40937D1Q37360204-78C82147-6A01-49F0-B9D2-790F1C8DA630Q37444250-389F854E-4CDF-40B6-9C79-C6C82B1FB34DQ37460346-49F05A22-148C-4556-B6C0-5C1EC52497D3Q37494004-CA4D31CA-183C-498E-BDF6-F899E15675DDQ37564872-BEF1DA58-0C21-4D89-A879-170B03D918F4Q37616597-6EE02011-3115-49E8-A2CE-C1AB0F80EFDEQ37691930-549443E1-028D-467A-ACCF-58DF3D887891Q39280068-89145343-82FF-4D91-8A23-3AB8AA5D23DEQ39320280-94619E52-A404-4F11-8CA2-643ACE482DE5Q39709581-E71783E8-8935-4F6D-82C3-3663C76D73B0Q40054917-EB43364A-581D-4598-878C-9C7786B313FBQ42948389-040F9114-E253-417C-8404-01576C3952D6Q53013971-BA76D37F-B68D-4670-A3BE-A5DF8ECDA450
P2860
Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Radioiodine therapy of colon c ...... odide symporter gene transfer.
@en
type
label
Radioiodine therapy of colon c ...... odide symporter gene transfer.
@en
prefLabel
Radioiodine therapy of colon c ...... odide symporter gene transfer.
@en
P2093
P2860
P356
P1433
P1476
Radioiodine therapy of colon c ...... odide symporter gene transfer.
@en
P2093
Bergert ER
Harrington KJ
Spitzweg C
P2860
P2888
P304
P356
10.1038/SJ.GT.3302410
P577
2005-02-01T00:00:00Z
P5875
P6179
1037513322